CVE-2025-52653

MEDIUM EPSS 14.5%

Published Oct 3, 20259mo ago · Modified Jun 17, 20262w ago

5.4 CVSS 3.1

Medium

Published Oct 3, 2025 9mo ago

Last Modified Jun 17, 2026 2w ago

Description

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

CVSS Details

Base Score

5.4

Exploitability

2.3

Impact

2.7

Vector string

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector Network

Attack Complexity Low

Privileges Required Low

User Interaction Required

Scope Changed

Confidentiality Low

Integrity Low

Availability None

Threat Intelligence

EPSS Exploit Probability

14.5% percentile

Exploit & Patch Status

No Known Exploit

No Patch Available

Weaknesses 1

CWE-79 Cross-site Scripting Injection

Affected Products 1

Vendor	Product	Version	Range
hcltech	dryice_myxalytics	6.6	any

References 1

support.hcl-software.com https://support.hcl-software.com/csm?id=kb_article&sysparm_article=KB0124411

Vendor Advisory

Remediation

No remediation data recorded yet

Check vendor advisories and the NVD entry for patch availability.